Read the full article here: https://bit.ly/2TPriMf
Contact HiTech Health here for more information.
Recent News
ATMP Sector Spotlight: H1 2025 Review
The HiTech Health team has reviewed recent developments in the Advanced Therapeutic Medicinal Product (ATMP) sector during the first half of 2025. Below are some key updates from the industry so far: Sector Summary: In Europe, the ATMP sector is on track to...
Developing an Investigational Medicinal Product (IMP)? Considering conducting clinical trials in the UK?
The global clinical trials market is expected to nearly double to over £80 billion by 2032 and the United Kingdom remains one of the world’s leading destinations for conducting clinical research. Notably, the UK accounts for approximately 9.5% of all global cell and...
CanVas Consortium including HiTech Health receives €10.7 million DTIF grant to advance new class of cell therapy to clinic for early brain injury
Dublin, Ireland, 10th April 2025 – HiTech Health, a Contract Development and Manufacturing Organisation (CDMO) specialising in advanced medicines, is delighted to communicate that the CanVas consortium led by HAON life sciences (a leading cell therapy biotech company)...
Stay Up To Date
Connect with us to receive the latest HiTech Health and industry updates.